Development and Evaluation of Nanostructured Lipid Carriers for Enhanced Oral Bioavailability of Poorly Soluble Antihypertensive Drugs. Pjmcr 2026, 4 (1), 6963-6973. https://doi.org/10.66021/pakmcr1645.